The FY2025 (Dec) proxy of Heron Therapeutics, Inc. /De/ names 19 peer companies for pay. Among Heron Therapeutics, Inc. /De/ and these peers, CEO pay was the lowest of 7 and total shareholder return was the lowest of 7.
7th highest of 7in Heron Therapeutics, Inc. /De/ and its pay peers, FY2025 (Dec) by CEO pay:
$3.5M$8.5M
7th highest of 7in Heron Therapeutics, Inc. /De/ and its pay peers, FY2025 (Dec) by total shareholder return:
$6$264
Pay peer group, FY2025 (Dec) proxy
| Travere Therapeutics | ||
| Innoviva | ||
| Rigel Pharmaceuticals | ||
| UroGen Pharma | ||
| Vanda Pharmaceuticals | ||
| Lexicon Pharmaceuticals | ||
| Ani Pharmaceuticals | Not disclosed | Not disclosed |
| Akebia Therapeutics | Not disclosed | Not disclosed |
| Coherus BioSciences | Not disclosed | Not disclosed |
| Collegium Pharmaceuticals | Not disclosed | Not disclosed |
| Esperion Therapeutics | Not disclosed | Not disclosed |
| G1 Therapeutics | Not disclosed | Not disclosed |
| Harrow | Not disclosed | Not disclosed |
| Ocular Therapeutics | Not disclosed | Not disclosed |
| OptiNose | Not disclosed | Not disclosed |
| Phantom Pharmaceuticals | Not disclosed | Not disclosed |
| Sage Therapeutics | Not disclosed | Not disclosed |
| Xeris Biopharma Holdings | Not disclosed | Not disclosed |
| Y-mAbs Therapeutics | Not disclosed | Not disclosed |
19 companies
Changes by year
FY2025 (Dec) proxy
- AddedAkebia Therapeuticspay peer groupWe added Akebia Therapeutics, Harrow, Innoviva, Lexicon Pharmaceuticals, Sage Therapeutics, Travere Therapeutics, Urogen Pharma, and Y-mAbs Therapeutics to the peer group as they reflected a comparable size to our Company
- AddedHarrowpay peer groupWe added Akebia Therapeutics, Harrow, Innoviva, Lexicon Pharmaceuticals, Sage Therapeutics, Travere Therapeutics, Urogen Pharma, and Y-mAbs Therapeutics to the peer group as they reflected a comparable size to our Company
- AddedInnovivapay peer groupWe added Akebia Therapeutics, Harrow, Innoviva, Lexicon Pharmaceuticals, Sage Therapeutics, Travere Therapeutics, Urogen Pharma, and Y-mAbs Therapeutics to the peer group as they reflected a comparable size to our Company
- AddedLexicon Pharmaceuticalspay peer groupWe added Akebia Therapeutics, Harrow, Innoviva, Lexicon Pharmaceuticals, Sage Therapeutics, Travere Therapeutics, Urogen Pharma, and Y-mAbs Therapeutics to the peer group as they reflected a comparable size to our Company
- AddedSage Therapeuticspay peer groupWe added Akebia Therapeutics, Harrow, Innoviva, Lexicon Pharmaceuticals, Sage Therapeutics, Travere Therapeutics, Urogen Pharma, and Y-mAbs Therapeutics to the peer group as they reflected a comparable size to our Company
- AddedTravere Therapeuticspay peer groupWe added Akebia Therapeutics, Harrow, Innoviva, Lexicon Pharmaceuticals, Sage Therapeutics, Travere Therapeutics, Urogen Pharma, and Y-mAbs Therapeutics to the peer group as they reflected a comparable size to our Company
- AddedUroGen Pharmapay peer groupWe added Akebia Therapeutics, Harrow, Innoviva, Lexicon Pharmaceuticals, Sage Therapeutics, Travere Therapeutics, Urogen Pharma, and Y-mAbs Therapeutics to the peer group as they reflected a comparable size to our Company
- AddedY-mAbs Therapeuticspay peer groupWe added Akebia Therapeutics, Harrow, Innoviva, Lexicon Pharmaceuticals, Sage Therapeutics, Travere Therapeutics, Urogen Pharma, and Y-mAbs Therapeutics to the peer group as they reflected a comparable size to our Company
- RemovedAERIpay peer groupWhen compared to the compensation peer group utilized in considering the 2024 compensation levels, we removed Aeri Pharmaceuticals (AERI), Alberio Pharma (ALBO), Deciphera Pharmaceuticals (DCPH) and Intercept Pharmaceuticals (ICPT) as they merged with another company
- RemovedALBOpay peer groupWhen compared to the compensation peer group utilized in considering the 2024 compensation levels, we removed Aeri Pharmaceuticals (AERI), Alberio Pharma (ALBO), Deciphera Pharmaceuticals (DCPH) and Intercept Pharmaceuticals (ICPT) as they merged with another company
- RemovedAeri Pharmaceuticalspay peer groupWhen compared to the compensation peer group utilized in considering the 2024 compensation levels, we removed Aeri Pharmaceuticals (AERI), Alberio Pharma (ALBO), Deciphera Pharmaceuticals (DCPH) and Intercept Pharmaceuticals (ICPT) as they merged with another company
- RemovedAlberio Pharmapay peer groupWhen compared to the compensation peer group utilized in considering the 2024 compensation levels, we removed Aeri Pharmaceuticals (AERI), Alberio Pharma (ALBO), Deciphera Pharmaceuticals (DCPH) and Intercept Pharmaceuticals (ICPT) as they merged with another company
- RemovedDCPHpay peer groupWhen compared to the compensation peer group utilized in considering the 2024 compensation levels, we removed Aeri Pharmaceuticals (AERI), Alberio Pharma (ALBO), Deciphera Pharmaceuticals (DCPH) and Intercept Pharmaceuticals (ICPT) as they merged with another company
- RemovedDeciphera Pharmaceuticalspay peer groupWhen compared to the compensation peer group utilized in considering the 2024 compensation levels, we removed Aeri Pharmaceuticals (AERI), Alberio Pharma (ALBO), Deciphera Pharmaceuticals (DCPH) and Intercept Pharmaceuticals (ICPT) as they merged with another company
- RemovedEGRXpay peer groupWe removed Vericel (VCEL), Karyopharm Therapeutics (KPTI) and Eagle Pharmaceuticals (EGRX) as their size is no longer comparable and we removed EyePoint Pharmaceuticals (EYPT) as it was no longer an overall fit
- RemovedEyePointpay peer groupWe removed Vericel (VCEL), Karyopharm Therapeutics (KPTI) and Eagle Pharmaceuticals (EGRX) as their size is no longer comparable and we removed EyePoint Pharmaceuticals (EYPT) as it was no longer an overall fit
- RemovedEagle Pharmaceuticalspay peer groupWe removed Vericel (VCEL), Karyopharm Therapeutics (KPTI) and Eagle Pharmaceuticals (EGRX) as their size is no longer comparable and we removed EyePoint Pharmaceuticals (EYPT) as it was no longer an overall fit
- RemovedEyePoint Pharmaceuticalspay peer groupWe removed Vericel (VCEL), Karyopharm Therapeutics (KPTI) and Eagle Pharmaceuticals (EGRX) as their size is no longer comparable and we removed EyePoint Pharmaceuticals (EYPT) as it was no longer an overall fit
- RemovedICPTpay peer groupWhen compared to the compensation peer group utilized in considering the 2024 compensation levels, we removed Aeri Pharmaceuticals (AERI), Alberio Pharma (ALBO), Deciphera Pharmaceuticals (DCPH) and Intercept Pharmaceuticals (ICPT) as they merged with another company
- RemovedIntercept Pharmaceuticalspay peer groupWhen compared to the compensation peer group utilized in considering the 2024 compensation levels, we removed Aeri Pharmaceuticals (AERI), Alberio Pharma (ALBO), Deciphera Pharmaceuticals (DCPH) and Intercept Pharmaceuticals (ICPT) as they merged with another company
- RemovedKPTIpay peer groupWe removed Vericel (VCEL), Karyopharm Therapeutics (KPTI) and Eagle Pharmaceuticals (EGRX) as their size is no longer comparable and we removed EyePoint Pharmaceuticals (EYPT) as it was no longer an overall fit
- RemovedKaryopharm Therapeuticspay peer groupWe removed Vericel (VCEL), Karyopharm Therapeutics (KPTI) and Eagle Pharmaceuticals (EGRX) as their size is no longer comparable and we removed EyePoint Pharmaceuticals (EYPT) as it was no longer an overall fit
- RemovedVericelpay peer groupWe removed Vericel (VCEL), Karyopharm Therapeutics (KPTI) and Eagle Pharmaceuticals (EGRX) as their size is no longer comparable and we removed EyePoint Pharmaceuticals (EYPT) as it was no longer an overall fit
- RemovedVericelpay peer groupWe removed Vericel (VCEL), Karyopharm Therapeutics (KPTI) and Eagle Pharmaceuticals (EGRX) as their size is no longer comparable and we removed EyePoint Pharmaceuticals (EYPT) as it was no longer an overall fit
The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year. Each company counts TSR from its own start year, so two values compare only when the start years match.